PCSK9 and coronary artery disorder: leveraged MR to estimate the degree to which Lp(a) lowering explains the effect of PCSK9 inhibition on LAAS (in MEGASTROKE) and coronary artery disease.67 Genetic variants near PCSK9 were selected based on associations with circulating PCSK9 levels and LDL cholesterol levels in the UK Biobank.